Sartorius | SRT3 - Sales Revenues


Sartorius reported EUR911.8M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 17.61M 805K Dec/2025
Dianthus Therapeutics USD 463K 179K Mar/2026
Ionis Pharmaceuticals USD 268M 22M Jun/2026
IQVIA Holdings USD 4.37B 220M Jun/2026
Moderna USD 100M 289M Jun/2026
Organon & Co USD 1.56B 100M Jun/2026
Revvity USD 729.68M 18.68M Jun/2026
Sartorius EUR 911.8M 12.7M Jun/2026
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.76B 240M Jun/2026
Xeris Pharmaceuticals USD 83.13M 2.68M Mar/2026